PDCT-07. HERBY (BO25041): A PHASE II OPEN-LABEL, RANDOMIZED, MULTICENTER, COMPARATIVE STUDY OF BEVACIZUMAB (BEV)-BASED THERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG)
Grill, Jacques, Hargrave, Darren, Massimino, Maura, Bouffet, Eric, Azizi, Amedeo, McCowage, Geoffrey, Cañete, Adela, Saran, Frank, Le Deley, Marie-Cecile, Varlet, Pascale, Morgan, Paul S., Jaspan, TimVolume:
18
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now212.611
Date:
November, 2016
File:
PDF, 94 KB
english, 2016